Bibliometric analysis of liver cancer research, particularly in immunotherapy, reveals crucial insights. The US leads in liver cancer mortality but ranks fifth globally.
OBJECTIVE:
Scopus database analysis identified 2,349 papers, with the top 100 ranging from 127 to 4,959 citations. Notably, “Microenvironmental Regulation of Tumours Progression and Metastasis” in the Journal of Nature Medicine garnered the highest citations.
METHODS:
Journals like the Journal of Hepatology, Hepatology, and Nature Reports Clinical Oncology contributed significantly. Understanding molecular mechanisms and prognostic indicators is paramount for advancing combination therapies.
RESULTS:
For better patient outcomes, research trends in liver cancer immunotherapy point to improved treatment protocols, knowledge of the tumor microenvironment, combining therapies, predicting disease course, international cooperation, sophisticated surgical techniques, early detection, oncolytic virotherapy, and patient-centered care.
CONCLUSIONS:
This research underscores immunotherapy’s pivotal role and encourages further exploration, offering valuable insights into liver cancer treatment trends.
HausmanDM. What is cancer? Perspectives in Biology and Medicine.2019; 62(4): 778-84.
2.
Ali SyedaZLangdenSSMunkhzulCLeeMSongSJ. Regulatory mechanism of MicroRNA expression in cancer. International Journal of Molecular Sciences.2020 Mar 3; 21(5): 1723.
3.
SoussiT. p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Research.2000 Apr 1; 60(7): 1777-88.
4.
HoadleyKAYauCHinoueTWolfDMLazarAJDrillEShenRTaylorAMCherniackADThorssonVAkbaniR. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell.2018 Apr 5; 173(2): 291-304.
5.
HanahanD. Hallmarks of cancer: new dimensions. Cancer Discovery.2022 Jan 1; 12(1): 31-46.
6.
LondonWTMcglynnKA. Liver cancer. Cancer Epidemiology and Prevention.2006 Oct 12: 763-86.
7.
ThorgeirssonSSGrishamJW. Molecular pathogenesis of human hepatocellular carcinoma. Nature Genetics.2002 Aug 1; 31(4): 339-46.
8.
MarshallARushbrookSDaviesSEMorrisLSScottISVowlerSLColemanNAlexanderG. Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology.2005 Jan 1; 128(1): 33-42.
9.
CloustonADPowellEEWalshMJRichardsonMMDemetrisAJJonssonJR. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells, and steatosis. Hepatology.2005 Apr; 41(4): 809-18.
10.
FaraziPADePinhoRA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nature Reviews Cancer.2006 Sep 1; 6(9): 674-87.
11.
HussainSPSchwankJStaibFWangXWHarrisCC. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene.2007 Apr; 26(15): 2166-76.
12.
DharDBaglieriJKisselevaTBrennerDA. Mechanisms of liver fibrosis and its role in liver cancer. Experimental Biology and Medicine.2020 Jan; 245(2): 96-108.
13.
LiXRamadoriPPfisterDSeehawerMZenderLHeikenwalderM. The immunological and metabolic landscape in primary and metastatic liver cancer. Nature Reviews Cancer.2021 Sep; 21(9): 541-57.
14.
GaoYXYangTWYinJMYangPXKouBXChaiMYLiuXNChenDX. Progress and prospects of biomarkers in primary liver cancer. International Journal of Oncology.2020 Jul 1; 57(1): 54-66.
15.
ChenXLiuHPLiMQiaoL. Advances in non-surgical management of primary liver cancer. World Journal of Gastroenterology: WJG.2014 Nov 11; 20(44): 16630.
16.
LiuLCaoYChenCZhangXMcNabolaAWilkieDWilhelmSLynchMCarterC. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Research.2006 Dec 15; 66(24): 11851-8.
17.
MoehlerMGoepfertKHeinrichBBreitbachCJDelicMGallePRRommelaereJ. Oncolytic virotherapy as emerging immunotherapeutic modality: the potential of parvovirus h-1. Frontiers in Oncology.2014 May 1; 4: 92.
18.
CheungTTPoonRTYuenWKChokKSJenkinsCRChanSCFanSTLoCM. Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Annals of Surgery.2013 Mar 1; 257(3): 506-11.
19.
CarrollHKDuffyAGO’FarrellyC. Liver immunology, immunotherapy, and liver cancers: Time for a rethink? In Seminars in Liver Disease 2022 May (Vol. 42, No. 02, pp. 212-224). Thieme Medical Publishers, Inc.
20.
DillmanRO. Cancer immunotherapy. Cancer biotherapy & radiopharmaceuticals.2011 Feb 1; 26(1): 1-64.
21.
RileyRSJuneCHLangerRMitchellMJ. Delivery technologies for cancer immunotherapy. Nature Reviews Drug Discovery.2019 Mar; 18(3): 175-96.
22.
FukumuraDKloepperJAmoozgarZDudaDGJainRK. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nature reviews Clinical Oncology.2018 May; 15(5): 325-40.
23.
SathyaprakashPAlagarsundaramPDevarajanMVAlkhayyatAPoovendranPRaniDRSavitha,V. Medical Practitioner-Centric Heterogeneous Network Powered Efficient E-Healthcare Risk Prediction On Health Big Data. International Journal of Cooperative Information Systems.2024.
24.
KumarPMKamruzzamanMMAlfurhoodBSHossainBNagarajanHSitaramanSR. Balanced Performance Merit On Wind and Solar Energy Contact With Clean Environment Enrichment. IEEE Journal of the Electron Devices Society.2024.
25.
BreousEThimmeR. Potential of immunotherapy for hepatocellular carcinoma. Journal of Hepatology.2011 Apr 1; 54(4): 830-4.
26.
HodiFSO’DaySJMcDermottDFWeberRWSosmanJAHaanenJBGonzalezRRobertCSchadendorfDHasselJCAkerleyW. Improved survival with ipilimumab in patients with metastatic melanoma. New England Journal of Medicine.2010 Aug 19; 363(8): 711-23.
27.
SznolMChenL. Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in treating advanced human cancer. Clinical Cancer Research.2013 Mar 1; 19(5): 1021-34.
28.
ShiFShiMZengZQiRZLiuZWZhangJYYangYPTienPWangFS. PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients. International Journal of Cancer.2011 Feb 15; 128(4): 887-96.
29.
TopalianSLHodiFSBrahmerJRGettingerSNSmithDCMcDermottDFPowderlyJDCarvajalRDSosmanJAAtkinsMBLemingPD. Safety, activity, and immune correlates of anti–PD–1 antibody in cancer. New England Journal of Medicine.2012 Jun 28; 366(26): 2443-54.
30.
LiangJDingTGuoZWYuXJHuYZZhengLXuJ. Expression pattern of tumor-associated antigens in hepatocellular carcinoma: association with immune infiltration and disease progression. British Journal of Cancer.2013 Aug; 109(4): 1031-9.
31.
ButterfieldLHRibasADissetteVBLeeYYangJQDe la RochaPDuranSDHernandezJSejaEPotterDMMcBrideWH. A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides. Clinical Cancer Research.2006 May 1; 12(9): 2817-25.
32.
ZhangQZhangZPengMFuSXueZZhangR. CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedside. Oncoimmunology.2016 Dec 1; 5(12): e1251539.
33.
GretenTFMauda-HavakukMHeinrichBKorangyFWoodBJ. Combined locoregional immunotherapy for liver cancer. Journal of Hepatology.2019 May 1; 70(5): 999-1007.
34.
FoersterFGairingSJIlyasSIGallePR. Emerging immunotherapy for HCC: A guide for hepatologists. Hepatology.2022 Jun 1; 75(6): 1604-26.
35.
KimHJYoonDYKimESLeeKBaeJSLeeJH. The 100 most-cited articles in neuroimaging: a bibliometric analysis. Neuroimage.2016 October 1; 139: 149-56.
36.
YinXChengFWangXMuJMaCZhaiCWangQ. Top 100 cited articles on rheumatoid arthritis: a bibliometric analysis. Medicine.2019 Feb 1; 98(8): e14523.
37.
IqbalURehanAAkmalMJamaliMIqbalAKhanBAWasifKURiveraEKhanM. Top 100 most influential articles in the field of myeloid neoplasms: a bibliometric study. Acta Haematologica.2019 Feb 1; 141(2): 68-78.
38.
UllahWAbdullahHMAhmadERashidMUBashirMRahmanAUAhmadAHurairahAAbdullahHM. A bibliometric analysis of the top 100 cited hepatic magnetic resonance imaging articles. Cureus.2018 Jun 4; 10(6).
39.
FeijooJFLimeresJFernández-VarelaMRamosIDizP. The 100 most cited articles in dentistry. Clinical oral investigations.2014 Apr; 18: 699-706.
40.
KreutzerJSAgyemangAAWeedonDZaslerNOliverMSorensenAAvan WijngaardenSLeahyE. The top 100 cited neurorehabilitation papers. NeuroRehabilitation.2017 Jan 1; 40(2): 163-74.
41.
Jusue-TorresIHulbertAGermanwalaAAPatelCRGermanwalaAV. The 100 most-cited reports about craniopharyngioma. World Neurosurgery.2018 Nov 1; 119: e910-21.
42.
UysalE. Top 100 cited classic articles in breast cancer research. European Journal of Breast Health.2017 Jul; 13(3): 1.
